INFECTION PREVENTION
Inserting best practices with every catheter
by Nancy Pasternack Photo credit:
Photographee.eu |
stock.adobe.com T
wo years ago, Ben Galvan, an Infection Preventionist, worked in relative obscurity at Tampa General Hospital (TGH) in Florida. He audited quality care practices for central venous catheters (CVCs) and other medical devices, conducted surveillance for healthcare-associated infections (HAIs), developed procedures and trained staff to prevent infec- tion transmission, and generally spread the good word of good hygiene throughout the hospital. ut after helping fight against HAIs through month after month
of the pandemic, his job is now center stage, and Galvan’s team of eight (plus a director and manager) — are considered heroes. In June, 2021, they received the 2021 Heroes of Infection Prevention Award from the Association for Professionals in Infection Control and Epidemiology (APIC). The award specifi- cally honored the team’s Outstanding COVID-19 response. Prior to COVID-19, “A lot of people might not have realized who we were,” Galvan said of the team’s role. ut during a time that has seen ICU beds filled, and unprec- edented hospital staffing shortages, HAIs have been difficult to prevent. Patient-facing departments looked to Galvan’s work, and that of his colleagues, for information and recommendations. Nationally, the Centers for Disease Control and Prevention (CDC) reported significant increases of HAI cases from 019 to 2020.1
The usual suspects, including central line-associated bloodstream infection (CLABSI), catheter-associated urinary tract infection (CAUTI), ventilator-associated events (VAE), each left its mark.
CLABSI in intensive care units (ICUs) saw a 50% increase in CLABSI cases in 2020 over 2019. During the especially hard-hit fourth quarter of 2020, cases increased by 65% over the fourth quarter of 2019. The same fourth quarter-to-fourth-quarter ICU comparison for CAUTI revealed a 30% increase. For VAE, ICU infection rates increased by 44%.
“We were in crisis mode for a long time,” Galvan said of
COVID-19’s widespread impact. “Lots of patients had lots of (IV) lines and were incredibly sick.” It was difficult for hospitals everywhere to pre- vent HAIs when they were packed with seriously ill patients requiring a high level of care, Galvan says. Staffing shortages left lower nurse-to-bed ratios than normal, and immunity-suppressing factors such as high steroid and antibiotic use raised the likeli- hood of infections.
Ben Galvan
The staff at TGH got a brief mid-fall respite when the volume of COVID-19 patients tapered off. But before the next big surge, a full-blown COVID-inuenza “twindemic, or another virulent mutant strain shows up, Galvan says it’s time, “to get back to the nuts and bolts,” of infection prevention.
He lists some of the most likely and dangerous places where bacteria lurk. “IV pumps themselves can be a source of infection if not cleaned properly,” he said. “Central line care — the catheter itself — has to be secured, not tugging on the skin, which can cause micro- tears. We want to make sure our IV tubing is not expired and that it’s labeled properly. The dressing right around the (catheter) insertion site must be clean, and changed as needed.” Preventing contamination of the insertion site is key, he says, and using anti-microbial dressings can help.
Pathogen-fighting products Products designed to help prevent HAIs play an important role in infection prevention. Choosing them wisely can make a difference. Teleex makes antimicrobial vascular products that include the catheter itself. Chlorhexidine and silver sulfadiazine,
22 January 2022 • HEALTHCARE PURCHASING NEWS •
hpnonline.com
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52